Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race
- PMID: 36404491
- PMCID: PMC10067026
- DOI: 10.1002/cam4.5439
Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race
Abstract
Purpose: To determine if the COVID-19 pandemic has further exacerbated racial disparities in late-stage presentation of breast, colorectal, lung, and prostate cancers.
Methods: We conducted a registry-based retrospective study of patients with newly reported diagnoses of breast, colorectal, lung, and prostate cancers between March 2019-June 2019 (pre-COVID-19) and March 2020-June 2020 (early-COVID-19). We compared the volume of new diagnoses and stage at presentation according to race between both periods.
Results: During the study period, a total of 3528 patients had newly diagnosed cancer; 3304 of which had known disease stages and were included in the formal analyses. 467 (14.1%) were Blacks, and 2743 were (83%) Whites. 1216 (36.8%) had breast, 415 (12.6%) had colorectal, 827 (25%) had lung, and 846 (25.6%) had prostate cancers, respectively. The pre-COVID-19 period included 2120 (64.2%), and the early-COVID-19 period included 1184 (35.8%), representing a proportional 44.2% decline in the volume of new cases of breast, colorectal, lung, and prostate cancers, p < 0.0001. Pre-COVID-19, 16.8% were diagnosed with metastatic disease, versus 20.4% early-COVID-19, representing a proportional increase of 21.4% in the numbers of new cases with metastatic disease, p = 0.01. There was a non-significant proportional decline of 1.9% in Black patients diagnosed with non-metastatic breast, colorectal, lung, and prostate cancers early-COVID-19 (p = 0.71) and a non-significant proportional increase of 7% in Black patients diagnosed with metastatic disease (p = 0.71). Difference-in-difference analyses showed no statistically significant differences in metastatic presentation comparing Black to White patients.
Conclusion: While we identified substantial reductions in the volume of new cancer diagnoses and increases in metastatic presentations due to the COVID-19 pandemic, the impact was similar for White and Black patients.
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures


Similar articles
-
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.JAMA Oncol. 2021 Feb 1;7(2):220-227. doi: 10.1001/jamaoncol.2020.6178. JAMA Oncol. 2021. PMID: 33300956 Free PMC article.
-
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884. JAMA Oncol. 2021. PMID: 33914015 Free PMC article.
-
Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.CMAJ Open. 2023 Jun 6;11(3):E475-E484. doi: 10.9778/cmajo.20220092. Print 2023 May-Jun. CMAJ Open. 2023. PMID: 37279981 Free PMC article.
-
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.Heart Fail Rev. 2019 Nov;24(6):989-995. doi: 10.1007/s10741-019-09808-y. Heart Fail Rev. 2019. PMID: 31175492 Review.
-
The identification of incident cancers in UK primary care databases: a systematic review.Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):11-8. doi: 10.1002/pds.3729. Epub 2014 Nov 24. Pharmacoepidemiol Drug Saf. 2015. PMID: 25421570
Cited by
-
The stage of head and neck diagnosed malignancies in COVID-19 outbreak versus before outbreak: A retrospective study.Cancer Rep (Hoboken). 2023 May;6(5):e1801. doi: 10.1002/cnr2.1801. Epub 2023 Mar 16. Cancer Rep (Hoboken). 2023. PMID: 36924074 Free PMC article.
-
Impact of the COVID-19 Pandemic on Gut Cancer Admissions and Management: A Comparative Study of Two Pandemic Years to a Similar Pre-Pandemic Period.Healthcare (Basel). 2025 Apr 3;13(7):805. doi: 10.3390/healthcare13070805. Healthcare (Basel). 2025. PMID: 40218102 Free PMC article.
-
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.Cancer Med. 2023 Nov;12(22):20918-20929. doi: 10.1002/cam4.6637. Epub 2023 Nov 1. Cancer Med. 2023. PMID: 37909210 Free PMC article.
-
Establishment and clinical value of a circulating tumor cell system based on a multi-site immune lipid magnetic sphere technique in laryngopharyngeal head and neck tumors.Am J Cancer Res. 2025 Jan 15;15(1):19-31. doi: 10.62347/MVRG3697. eCollection 2025. Am J Cancer Res. 2025. PMID: 39949932 Free PMC article.
-
Building research infrastructure to advance precision medicine in colorectal cancer.JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf027. doi: 10.1093/jncics/pkaf027. JNCI Cancer Spectr. 2025. PMID: 40111849 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical